Aspen Investment Management’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Aspen Investment Management’s Portfolio RXII Stock Details RXII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-15,000	Closed	-$5K	–	133
2016 Q3	$5K	Hold	15,000	–	–	﹤0.01%	124
2016 Q2	$7K	Buy	+15,000	New	+$7K	0.01%	126

Aspen Investment Management's RXII Position: Q4 2016 in Review

Aspen Investment Management sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 15,000 shares — an estimated $5K sold.

Aspen Investment Management first reported a position in RXII in Q2 2016 and held it in 2 quarters. The position peaked at $7K in Q2 2016. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.

Aspen Investment Management reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
Aspen Investment Management sold 15,000 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $5K.
Aspen Investment Management first reported a position in GALENA BIOPHARMA INC COM in Q2 2016 and held it in 2 quarters.
Aspen Investment Management's GALENA BIOPHARMA INC COM position peaked at $7K in Q2 2016.
0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.

Based on Aspen Investment Management's 13F filing for Q4 2016, filed 27 Feb 2017.